Research-based biopharmaceutical company, Pfizer Inc.’s Chief Executive Officer Albert Bourla informed on Sunday that he has tested positive for Covid-19. Giving his health update he said, “I have tested positive for COVID. I’m feeling well & symptom free.”
I have tested positive for COVID. I’m feeling well & symptom free. I’ve not had the new bivalent booster yet, as I was following CDC guidelines to wait 3 months since my previous COVID case which was back in mid-August. While we’ve made great progress, the virus is still with us.
— Albert Bourla (@AlbertBourla) September 24, 2022
This is the second time in six weeks that Pfizer’s CEO has contracted Coronavirus. Bourla was Covid-19 positive in August even after being vaccinated four times. The pharma chief received initial two shots and two boosters, both of Pfizer’s mRNA vaccine. He however did not receive the company’s new bivalent booster shot. He had earlier claimed that Pfizer’s vaccine was “100% effective” in preventing coronavirus infection.
While he was contracted with COVID in August, he took a course of Pfizer’s oral COVID-19 antiviral treatment, Paxlovid. Paxlovid is an antiviral medication that is used to treat high-risk people, such as older patients.
The new bivalent booster shot targets the Omicron variant of the coronavirus and its substrains, BA.5 and BA.4. However, the shot has not been so popular among the American population. According to the data collected by the Centers for Disease Control and Prevention (CDC), only 1.5% of eligible people in the US have taken the jab. This was three weeks after the shot was approved by the Food and Drug Administration (FDA).
This week, a federal health organisation said that more than 25 million doses of the alleged bivalent shots had been distributed. Due to the rampant production of the Moderna vaccine, that mainly included the Pfizer/BioNTech vaccine.
